Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,741 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

NCT01099722

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Sofia, Bulgaria
  • Csongrád Megyei Önkormányzat Mellkasi Betegségek Szakkórháza Tüdőgondozó Intézet Szeged, Hungary
  • Indore, India
  • Krakow, Poland
View Trial Details
Completed

Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma

NCT02814643

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Mesa, Arizona, United States
  • Research Site Huntington Beach, California, United States
  • Research Site Newport Beach, California, United States
View all 24 locations
View Trial Details
Completed

An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

NCT00563056

Conditions
Asthma, Asthma Bronchiale, Bronchial Diseases, +7 more
Locations
  • Research Site Kassel, Germany
  • Research Site Érd, Hungary
  • Research site Nieuwegein, Netherlands
  • Research Site Krakow, Poland
View Trial Details
Completed

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

NCT02414854

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational Site Number 840047 Birmingham, Alabama, United States
  • Investigational Site Number 840056 Flagstaff, Arizona, United States
  • Investigational Site Number 840099 Gilbert, Arizona, United States
  • Investigational Site Number 840087 Scottsdale, Arizona, United States
View all 389 locations
View Trial Details
Completed

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

NCT02753712

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • The Woolcock Institute of Medical Research Glebe, New South Wales, Australia
  • Epworth Eastern Medical Centre Box Hill, Victoria, Australia
  • Allergy immunology and Respiratory medicine, The Alfred Hospital Melbourne, Victoria, Australia
  • The New Zealand Respiratory and Sleep Institute Greenlane, Auckland, New Zealand
View all 16 locations
View Trial Details

Related conditions